Classics in Chemical Neuroscience: Donepezil

被引:57
作者
Brewster, James T., II [1 ]
Dell'Acqua, Simone [2 ]
Thach, Danny Q. [3 ]
Sessler, Jonathan L. [1 ]
机构
[1] Univ Texas Austin, Dept Chem, Austin, TX 78712 USA
[2] Univ Pavia, Dept Chem, Via Taramelli 12, I-27100 Pavia, Italy
[3] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA
基金
美国国家卫生研究院;
关键词
Donepezil; cholinergic hypothesis; acetylcholinesterase inhibitor; Alzheimer's disease; neurodegeneration; Classics in Chemical Neuroscience; AMYLOID-BETA-PEPTIDE; CHROMATOGRAPHY-MASS-SPECTROMETRY; SEVERE ALZHEIMERS-DISEASE; CHANGES FOLLOWING SINGLE; ACETYLCHOLINESTERASE INHIBITORS; PHARMACOKINETIC CHANGES; CHOLINESTERASE-INHIBITORS; PHARMACODYNAMIC PROFILE; HYDROCHLORIDE E2020; MESSENGER-RNA;
D O I
10.1021/acschemneuro.8b00517
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The discovery of acetylcholine and acetylcholinesterase provided the first insight into the intricacies of chemical signal transduction and neuronal communication. Further elucidation of the underlying mechanisms led to an attendant leveraging of this knowledge via the synthesis of new therapeutics designed to control aberrant biochemical processes. The central role of the cholinergic system within human memory and learning, as well as its implication in Alzheimer's disease, has made it a point of focus within the neuropharmacology and medicinal chemistry communities. This review is focused on donepezil and covers the background, synthetic routes, structure activity relationships, binding interactions with acetylcholinesterase, pharmacokinetics and metabolism, efficacy, adverse effects, and historical importance of this leading therapeutic in the treatment of Alzheimer's disease and true Classic in Chemical Neuroscience.
引用
收藏
页码:155 / 167
页数:25
相关论文
共 208 条
[91]   Effect of donepezil hydrochloride (E2020) on basal concentration of extracellular acetylcholine in the hippocampus of rats [J].
Kosasa, T ;
Kuriya, Y ;
Matsui, K ;
Yamanishi, Y .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1999, 380 (2-3) :101-107
[92]   Molecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision Medicine [J].
Kovacs, Gabor G. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)
[93]   Structure of acetylcholinesterase complexed with E2020 (Aricept®):: implications for the design of new anti-Alzheimer drugs [J].
Kryger, G ;
Silman, I ;
Sussman, JL .
STRUCTURE, 1999, 7 (03) :297-307
[94]   A review on Alzheimer's disease pathophysiology and its management: an update [J].
Kumar, Anil ;
Singh, Arti ;
Ekavali .
PHARMACOLOGICAL REPORTS, 2015, 67 (02) :195-203
[95]   Up-regulation of nicotinic acetylcholine receptors by central-type acetylcholinesterase inhibitors in rat cortical neurons [J].
Kume, T ;
Sugimoto, M ;
Takada, Y ;
Yamaguchi, T ;
Yonezawa, A ;
Katsuki, H ;
Sugimoto, H ;
Akaike, A .
EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 527 (1-3) :77-85
[96]  
Lee P.E., 2011, BC Medical Journal, V53, P404
[97]  
LI Y, 1991, J BIOL CHEM, V266, P23083
[98]   Role of sigma-1 receptors in neurodegenerative diseases [J].
Linda Nguyen ;
Lucke-Wold, Brandon P. ;
Mookerjee, Shona A. ;
Cavendish, John Z. ;
Robson, Matthew J. ;
Scandinaro, Anna L. ;
Matsumoto, Rae R. .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2015, 127 (01) :17-29
[99]   Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings (Reprinted from Advanced Drug Delivery Reviews, vol 23, pg 3-25, 1997) [J].
Lipinski, CA ;
Lombardo, F ;
Dominy, BW ;
Feeney, PJ .
ADVANCED DRUG DELIVERY REVIEWS, 2001, 46 (1-3) :3-26
[100]  
Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007